Regulatory mechanism of glutathione S-transferase P-form during chemical hepatocarcinogenesis: Old wine in a new bottle

Cancer Letters

Volumn 209, Issue 2, 2004, Pages 155-163

  Higashi, Ken ^a   Hiai, Hiroshi ^a   Higashi, Taneaki ^b   Muramatsu, Masami ^c  

^a KYOTO UNIVERSITY   (Japan)

^b KOSHIEN UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemical carcinogen; Epigenetic mechanism; Genetic linkage map; Glutathione S transferase P form; Liver enriched transcription factors

Indexed keywords

CARCINOGEN; CCAAT ENHANCER BINDING PROTEIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEPATOCYTE NUCLEAR FACTOR 3; HEPATOCYTE NUCLEAR FACTOR 4; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CANCER GENETICS; CANCER GROWTH; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GROWTH REGULATION; LIVER CARCINOGENESIS; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; PRECANCER; PRIORITY JOURNAL; SHORT SURVEY;

EID: 2442638662     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.01.003     Document Type: Article

References (60)

1. Satoh K., Kitahara A., Soma Y., Inaba Y., Hatayama I., Sato K. Purification, induction, and distribution of placental glutathione S-transferase: a new marker enzyme for preneoplastic cells in rat chemical hepatocarcinogenesis. Proc. Natl Acad. Sci. USA. 85:1984;3964-3968
2. Sato K. Glutathione S-transferases as markers of preneoplasia and neoplasia. Adv. Cancer Res. 1984;205-255
3. Ito N., Hasegawa R., Imaida K., Hirose M., Shirai T. Medium-term liver and multi-organ carcinogenesis and chemopreventive agents. Exp. Toxicol. Pathol. 48:1996;113-119
4. Ito N., Tamano S., Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci. 94:2003;3-8
5. Rao M.S., Tatematsu M., Subbarao V., Ito N., Reddy K. Analysis of peroxisome proliferators-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma- glutamyltranspeptidase. Cancer Res. 46:1986;5287-5290
6. Abramovitz M., Listowsky I. Developmental regulation of glutathione S-transferase. Xenobiotics. 18:1988;1249-1254
7. Hatayama I., Satoh K., Sato K. Developmental and hormonal regulation of the major form of hepatic glutathione S-transferase in male mice. Biochem. Biophys. Res. Comm. 140:1986;581-588
8. Hayes P.C., May L., Hayes J.D., Harrison D.J. Glutathione S-transferases in human liver cancer. Gut. 32:1991;1546-1549
9. Moriyama S., Suzuki T., Hochi S., Yuki A., Nomura K., Kitagawa T., et al. Trans-activation of glutathione S-transferase P gene during chemical hepatocarcinogenesis of the rat. Proc. Natl Acad. Sci. USA. 90:1993;2065-2068
10. Sakai M., Okuda A., Muramatsu M. Multiple regulatory elements and phorbol 12-o-tetradecanoate 13-acetate. Proc. Natl Acad. Sci. USA. 85:1988;9456-9460
11. Hayes J.D., Pulford D.J. The glutathione S-transferase superfamily: regulation of GST and the contribution of the isozyme to cancer prevention and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600
12. Okuda A., Imagawa M., Sakai M., Muramatsu M. Functional cooperativity between two TPA responsive elements in undifferentiated F9 embryonic stem cells. Eur. Mol. Biol. Org. J. 9:1990;1131-1135
13. Diccianni M.B., Imagawa M., Muramatsu M. The dyad palindromic glutathione transferase P enhancer binds multiple factors including AP1. Nucleic Acids Res. 20:1992;5153-5158
14. Sakai M., Matsushima-Hibiya Y., Nishizawa M., Nishi S. Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun and peroxisome proliferators-activated receptor alpha. Cancer Res. 55:1995;5370-5376
15. Kuo M.H., Allis C.D. In vivo cross-linking and immunoprecipitation for studying dynamic protein:DNA association in a chromatin environment. Methods. 19:1999;425-433
16. Kang S.H., Vieira K., Bungert J. Combining chromatin immunoprecipitation and DNA footprinting: a novel method to analyze protein-DNA interaction in vivo. Nucleic Acids Res. 30:2002;e44
17. Bammler T.K., Smith C.A., Wolf C.P. Isolation and characterization of two mouse Pi-class glutathione S-transferase genes. Biochem. J. 298:1994;385-390
18. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying genes through antioxidant response elements. Biochem. Biophys. Res. Comm. 236:1997;313-322
19. Kwak M.K., Itoh K., Yamamoto M., Sutter T.R., Kensler T.W. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethione-3- thione. Mol. Med. 7:2001;135-145
20. Favreau L.V., Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinine reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by plant aromatic compounds and phenolic antioxidants. J. Biol. Chem. 266:1991;4556-4561
21. Kawamoto K., Nakamura Y., Uchida K. Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes. J. Biol. Chem. 275:2000;11291-11299
22. Satoh K., Itoh K., Yamamoto M., Tanaka M., Hayakari M., Ookawa K., et al. Nrf2 transactivator-independent GST-P1-1 expression in GST-P1-1 positive single cells in female mouse liver by DEN: a preneoplastic character of possible initiated cells. Carcinogenesis. 23:2002;457-462
23. Imagawa M., Osada S., Okuda A., Muramatsu M. Silencer binding proteins function on multiple cis-elements in the glutathione transferase P gene. Nucl. Acids Res. 19:1991;5-10
24. Osada S., Daimon S., Ikeda T., Nishihara T., Yano K., Yamasaki M., Imagawa M. Nuclear factor 1 family proteins bind to the silencer element in the rat glutathione transferase P gene. J. Biochem. 121:1997;355-363
25. Xanthopoulos K.G., Mirkovitch J. Gene regulation in rodent hepatocytes during development, differentiation and disease. Eur. J. Biochem. 216:1993;353-370
26. Kuo C.J., Conley P.B., Chen L., Sladek F.M., Darnell J.E. Jr., Crabtree G.R. A transcriptional hierarchy involved in mammalian cell-type specification. Nature. 355:1992;457-461
27. Flodby P., Likado D.Z., Blanck A., Xanthopoulos K.G., Hallstrom I.P. Expression of the liver-enriched transcription factors C/EBP alpha, C/EBP-beta, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol. Carcinog. 12:1995;103-109
28. Hudson E.A., Munks R.J.L., Manson M.M. Characterization of transcriptional regulation of gamma-glutamyltranspeptidase in rat liver involving both positive and negative regulatory elements. Mol. Carcinog. 20:1997;376-388
29. Bois-Joyeux B., Danan J.L. Members of CCAAT/enhancer binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha-fetoprotein promoter and enhancer. Biochem. J. 301:1994;49-55
30. Cereghini S., Ott M., Power S., Maury M. Expression patterns of vHNF-1 and HNF-1 homeoproteins in early postplantation embryos suggest distinct and sequential developmental roles. Development. 116:1993;783-797
31. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. Fed. Am. Soc. Exp. Biol. J. 10:1996;267-282
32. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365:2002;561-575
33. Wang H., Iakova P., Wilde M., Welm A., Goode T., Roesler W.J., Timchenko N.A. C/EBP-alpha arrests cell proliferation through direct inhibition of cdk2 and cdk4. Mol. Cell. 8:2001;817-828
34. Mischoulon D., Rana B., Bucher N.I.R., Farmer S.R. Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBP alpha) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol. Cell. Biol. 12:1992;2553-2560
35. Buck M., Poli V., van der Geer P., Chojkier M., Hunter T. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP-beta is required for hepatocyte proliferation induced by TGF-alpha. Mol. Cell. 4:1999;1087-1092
36. Chojkier M. Signal transduction in the liver: C/EBP-beta modulates cell proliferation and survival. Hepatology. 37:2003;731-738
37. Luethy J.D., Holbrook N.J. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res. 52:1992;5-10
38. Guyton K.Z., Xu Q., Holbrook N.J. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. Biochem. J. 314:1996;547-554
39. Qiao D., Chen W., Stratagoules E.D., Martinez J.D. Bile acid-induced activation of activator protein kinase C signaling. J. Biol. Chem. 275:2000;15090-15098
40. Satoh K., Hatayama I. Anomalous elevation of glutathione S-transferase P-form (GST-P) in the elementary process of epigenetic initiation of chemical hepatocarcinogenesis in rats. Carcinogenesis. 23:2002;1193-1198
41. Wang X.Z., Lawson B., Brewer J.W., Zinszner H., Sanjay A., Sanjay A., et al. Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol. Cell. Biol. 16:1996;4273-4280
42. Ron D., Habener C.H.O.P. novel developmentally regulated nuclear protein that dimerizes with transcription factor C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev. 6:1992;439-453
43. Fukuda A., Nakamura Y., Ohigashi H., Osawa T., Uchida K. Cellular response to the redox active lipid peroxidation products: induction of glutathione S-transferase P by 4-hydroxy-2-nonenal. Biochem. Biophys. Res. Comm. 236:1997;505-509
44. Satoh K., Hayakari M., Ookawa K., Satou M., Aizawa S., Tanaka M., et al. Lipid peroxidation end products-responded induction of a preneoplastic marker enzyme glutathione S-transferase P-form (GST-P) in liver on administration via the portal vein. Mut. Res. 483:2001;65-72
45. Macleod M. A possible role in chemical carcinogenesis for epigenetic, heritable changes in gene expression. Mol. Carcinog. 15:1996;241-250
46. Suzuki T., Imagawa M., Yamada R., Yokoyama K., Kondo S., Itakura K., Muramatsu M. Acute changes in liver gene expression in the N- nitrosodiethylamine-treated rat. Carcinogenesis. 15:1994;1759-1761
47. Akira S., Ishii H., Tanabe T., Kinoshita S., Nishio Y., Nakajima T., et al. A nuclear factor for IL6 expression (NF-IL6) is a member of a C/EBP family. Eur. Mol. Biol. Org. J. 9:1990;1897-1906
48. Wegenka U.M., Buschmann J., Lutticken C., Heinrich P.C., Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol. Cell. Biol. 13:1993;276-288
49. Kato T., Imaida K., Osawa K., Hasegawa R., Shirai T., Tatematsu M. Three dimensional analysis of glutathione S-transferase placental form-positive lesion development in early stage of rat hepatocarcinogenesis. Jpn. J. Cancer Res. 84:1993;1252-1257
50. Pitot H.C., Sirica A.E. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta. 605:1980;191-215
51. Grasl-Kraupp B., Luebeck G.L., Wagner A., Loew-Baselli A., deGunst M., Waldhoer T., Moolgavhar S., Schulte-Hermann R. Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis. 21:2000;1411-1421
52. Enzmann H., Bannasch P. Potential significance of phenotypic heterogeneity of focal lesions at different stage in hepatocarcinogenesis. Carcinogenesis. 8:1989;1607-1612
53. Schwarz M., Buchmann A., Schulte M., Pearson D., Kunz W. Heterogeneity of enzyme-altered foci in rat liver. Toxicol. Lett. 49:1989;297-317
54. Denda A., Kitayama W., Konishi Y., Yan Y., Fukamachi Y., Miura M., et al. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats. Cancer Lett. 140:1999;59-67
55. Zeng Z.-Z., Higashi S., Kitayama W., Denda A., Yan Y., Matsuo K., et al. Genetic resistance to chemical carcinogen-induced preneoplastic hepatic lesions in DRH rats. Cancer Res. 60:2000;2876-2881
56. Yan Y., Zeng Z.-Z., Higashi S., Denda A., Konishi Y., Onishi S., et al. Resistance of DRH strain rats to chemical carcinogenesis of liver. genetic analysis of later progression stage. Carcinogenesis. 23:2002;189-196
57. Imai T., Masui T., Ichinose M., Nakanishi H., Yanai T., Masegi T., et al. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization. Carcinogenesis. 18:1997;545-551
58. De Miglio M.R., Simile M.M., Muroni M.R., Calvisi D.F., Virdis P., Asara G., et al. Phenotypic reversion of rat neoplastic liver nodules is under genetic control. Int. J. Cancer. 20:2003;70-75
59. VanGijssel H.E., Ohlson L.C., Torndal U.B., Mulder G.J., Eriksson L.C., Porsch-Hallstrom I., Meerman J.H. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo. Hepatology. 32:2000;701-710
60. Finnberg N., Silins I., Stenius U., Hogberg J. Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of preneoplastic lesions. Carcinogenesis. 25:2004;113-122